Rubric Capital Management (New York)’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.3M Buy
1,958,318
+740,584
+61% +$6.52M 0.26% 51
2025
Q1
$9.12M Buy
1,217,734
+601,611
+98% +$4.51M 0.16% 53
2024
Q4
$5.14M Buy
616,123
+596,123
+2,981% +$4.97M 0.07% 59
2024
Q3
$139K Buy
+20,000
New +$139K ﹤0.01% 63